EU:lle yhteinen linjaus biosimilaarien vaihtokelpoisuudesta - EU:ssa hyväksytty biosimilaari ja sen viitevalmisteena toimiva biologinen alkuperäislääke ovat keskenään vaihtokelpoisia fimea.fi/-/eu-lle-yhtei… #biosimilars #biosimilaari EU Medicines Agency

Saddened to learn of the death of David Bailey, Canada's first four-minute-miler and the scientist who discovered, by sheer serendipity, that grapefruit juice interacts with dozens of medications. I'll tell the story as David related it to me. theglobeandmail.com/canada/article… /1

Vielä on aikaa ilmoittaa kiinnostuksena tiedottajan tehtävään tai kysellä yksityiskohdista nykyiseltä @laurielsila! Still time to consider and apply! Ask details from the current Officer @laurielsila

Kliinisten lääketutkimusten hakemusmenettely muuttuu bit.ly/3UEu0kf #CTIS

Yhdistyksen aktiivitoimijat pj Mikko Niemi Mikko Niemi ja taloudenhoitaja Taavi Kaartinen Taavi Kaartinen ansaitusti mukana @mediuutiset listalla! Suomen Kliinisen Farmakologian Yhdistys onnittelee! 💐

Mark your calendars for the Second Nordic Conference on Personalized Medicine on 14-16 June 2023 in Turku, Finland! Registration and abstract submission will open in January. #norpm2023 Visit Turku Supported by Basic & Clinical Pharmacology & Toxicology norpm2023.fi

In 2018, we hosted the First Nordic Conference on Personalized Medicine and the Second Conference will be held this summer in beautiful Turku. Come join us for state-of-the-art research and fun!

➡️ Registration and abstract submission is open at the Conference web page at norpm2023.fi (early bird –deadline for registration 25 April 2023 and abstract deadline 31 March 2023). #norpm2023 #personalizedmedicine #turku #skfy #fscp

Upcoming: IUPHAR´s WCP2023 meeting, 2-7 July 2023 in Glasgow - Late Breaking abstract submission by 14th February - Early Bird Registration deadline 17th March Please find more info from: wcp2023.org/congress-infor…

Lancet: Ennakoiva testaus farmakogeneettisellä paneelitutkimuksella vähentää lääkkeiden haittavaikutuksia 30%! HUS Helsingin yliopistollinen sairaala toi vuosi sitten käyttöön 12 geenin farmakogeneettisen paneelitutkimuksen. thelancet.com/journals/lance…

We report three cases of rhabdomyolysis during concomitant use of ticagrelor and rosuvastatin, and propose a mechanism underlying the potential drug-drug interaction. A paper by Minna Lehtisalo & coworkers. IndiviDrug Medicine and Health, University of Helsinki bpspubs.onlinelibrary.wiley.com/doi/10.1111/bc…

Functional characterization of six rare non-synonymous variants in SLCO1B1, a paper by Katja Häkkinen, Wilma Kiander and coworkers. IndiviDrug Medicine and Health, University of Helsinki pubs.acs.org/doi/10.1021/ac…

Pahoitteluni väärästä linkistä, yksi numero putosi matkan varrella Sorry for a typo in the link Correct link is: uef.fi/fi/node/15238

Nordic Conference on Personalized Medicine on yksilöllisen lääketieteen tutkimukseen keskittyvä kongressi, joka kokoaa Turkuun kesällä 2023 niin akateemisia kuin teollisuudessa toimivia tutkijoita ympäri maailman. Suomen Kliinisen Farmakologian Yhdistys #norpm2023 utu.fi/fi/ajankohtais…

NORPM2023 Call for abstracts - deadline is 31 March 📩 Abstracts covering all aspects of the field of personalized medicine, including but not limited to pharmacogenetics, drug-drug interactions, therapeutic drug monitoring, etc. are invited. norpm2023.fi/abstracts #norpm2023

HOX! NORPM2023 Abstract deadline 31 March approaching! 📩 We welcome abstracts covering all aspects of the field of personalized medicine, including but not limited to pharmacogenetics, drug-drug interactions, therapeutic drug monitoring, etc. #norpm2023 norpm2023.fi

NORPM2023 starting in Turku, Finland with welcoming words. Going to have three days full of inspiring speakers, interesting posters and social programme. #norpm2023 #skfyfscp

The #ESPT2023 conference starting in Copenhagen with a keynote by Kim Brosen! Looking forward to 3 days full of pharmacogenetics, personalized therapy and interactions with great scientists! ESPTsociety Suomen Kliinisen Farmakologian Yhdistys

The #EACPT2024 congress starting in Rotterdam, Netherlands. Looking forward to the inspiring scientific program and networking.

EASL DHILI Consortium, along with IUPHAR is supporting the #EACPT2025 CONFERENCE for #clinicalpharmacology in Helsinki 😃 EACPT Suomen Kliinisen Farmakologian Yhdistys